National Institute of Neurological Disorders and Stroke

National Institute of Neurological Disorders and Stroke
Name	National Institute of Neurological Disorders and Stroke
Formed	0 1950
Headquarters	Bethesda, Maryland
Parent agency	National Institutes of Health
Chief1 name	Dr. Walter J. Koroshetz
Chief1 position	Director

National Institute of Neurological Disorders and Stroke. It is a component of the National Institutes of Health and the primary federal agency for conducting and supporting fundamental and clinical research on the brain and nervous system. The institute's mission is to seek fundamental knowledge about these systems and to use that knowledge to reduce the burden of neurological disease for all people. Its work encompasses a vast range of disorders, from stroke and epilepsy to Alzheimer's disease and amyotrophic lateral sclerosis.

History

The institute's origins trace back to the National Institute of Neurological Diseases and Blindness, which was established by the U.S. Congress in 1950 under the leadership of Senator Lister Hill and Representative John E. Fogarty. A pivotal moment in its evolution occurred in 1968 when the National Eye Institute was created, taking over vision research, and the neurological institute was renamed the National Institute of Neurological Diseases and Stroke. The final name change to the National Institute of Neurological Disorders and Stroke happened in 1975. Throughout its history, it has been headquartered on the campus of the National Institutes of Health in Bethesda, Maryland, and has been directed by notable figures such as Dr. Murray Goldstein and the current director, Dr. Walter J. Koroshetz.

Mission and research focus

The core mission is to reduce the burden of neurological disease through rigorous research. This involves gaining fundamental understanding of the normal nervous system and the mechanisms underlying disorders like Parkinson's disease, multiple sclerosis, and traumatic brain injury. The institute supports a broad portfolio, from basic neuroscience investigating neuron function to translational studies and large-scale clinical trials, such as those for acute stroke treatment. A key focus is on identifying biomarkers for diseases like Huntington's disease and developing novel therapies for conditions including spinal cord injury and brain tumors.

Organizational structure

The institute is led by a director, who oversees several critical divisions. The Division of Intramural Research conducts laboratory and clinical investigations directly at NIH facilities, while the extramural research is managed by the Division of Extramural Activities. Key programmatic divisions include the Division of Neuroscience, the Division of Translational Research, and the Division of Clinical Research. The institute also houses the National Institute on Drug Abuse and the National Institute of Mental Health within the broader NIH framework. Advisory bodies like the National Advisory Neurological Disorders and Stroke Council provide guidance on research priorities and funding allocations.

Major programs and initiatives

NINDS oversees several landmark, multi-institute initiatives. The Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative, launched by the Obama administration, is a major collaborative effort to map the brain's circuits. The institute also manages the NIH StrokeNet, a network coordinating clinical trials for stroke prevention and treatment across institutions like the Mayo Clinic and Massachusetts General Hospital. Other significant programs include the Parkinson's Disease Biomarkers Program and the Epilepsy Therapy Screening Program, which partner with entities such as the Michael J. Fox Foundation and the American Epilepsy Society.

Notable discoveries and advances

Research funded and conducted by the institute has led to transformative medical advances. It played a central role in the development and FDA approval of tissue plasminogen activator for acute ischemic stroke, a breakthrough that revolutionized emergency care. NINDS-supported scientists were instrumental in identifying genes responsible for familial forms of Alzheimer's disease and amyotrophic lateral sclerosis. Its clinical trials established effective surgical treatments for epilepsy and demonstrated the efficacy of deep brain stimulation for Parkinson's disease and essential tremor, work often conducted in collaboration with leading academic centers like Johns Hopkins University.

Public information and outreach

The institute provides extensive resources to educate both the public and healthcare professionals. It maintains the Brain Basics series and in-depth publications on conditions like migraine and peripheral neuropathy. Through the NIH Clinical Center, it offers information on participating in clinical research. NINDS also collaborates with patient advocacy groups, including the National Stroke Association and the ALS Association, to disseminate research findings. Its outreach extends to professional education for neurologists and neurosurgeons, often in partnership with organizations like the American Academy of Neurology.

Category:National Institutes of Health Category:Neurology organizations Category:United States Public Health Service Category:Medical and health organizations based in Maryland